NeoGenomics Names Warren Stone as Next CEO
NeoGenomics appointed Chief Operating Officer Warren Stone as its next chief executive, effective Jan. 4. Stone will succeed the current CEO, Tony Zook, who will assume a role of executive chair.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
5 results loaded, newest first. End of these results.
NeoGenomics Names Warren Stone CEO Effective Jan. 4
Warren Stone, currently President and Chief Operating Officer, will become the new CEO of NeoGenomics on January 4.
Neogenomics names Warren Stone CEO, Tony Zook becomes Executive Chairman
Neogenomics appointed Warren Stone as Chief Executive Officer effective January 4, 2027. Tony Zook will transition to Executive Chairman on the same date. Lynn Tetrault will step down as Board Chair, and Michael Kelly becomes Lead Independent Director.
NeoGenomics names Warren Stone CEO effective Jan. 4, 2027
NeoGenomics has appointed President and COO Warren Stone as CEO and a board member, effective Jan. 4, 2027. Stone, 54, previously held senior roles at Ortho Clinical Diagnostics and MilliporeSigma/Merck KGaA.
NeoGenomics names Warren Stone CEO as Tony Zook becomes Executive Chair
NeoGenomics announced a succession plan: Warren Stone will become CEO on Jan 4, 2027, with Tony Zook moving to Executive Chair. The company also expects preliminary Q3 revenue of $209 million and reiterated full-year guidance.